Login to Your Account



Pharma: Other News To Note


Wednesday, February 29, 2012
• Bristol-Myers Squibb Co., of New York, said it formed a relationship with Duke Translational Medicine Institute (DTMI), which will build on a decade of collaboration in cardiology, endocrinology and oncology and extend into other therapeutic areas at all stages of development.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription